Glycol, Pregelatinized Starch, Titanium Dioxide and Zinc stearate INDICATIONS AND CLINICAL USE DESLORATADINE ALLERGY CONTROL (desloratadine) tablets are indicated for: fast 24-hour and effective relief of multi nasal and non-nasal symptoms associated with allergic rhinitis, including sneezing, nasal

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Seizures Induced by Desloratadine, A Second-Generation Antihistamine: Clinical Observations

  2013cited by this paper
• A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.

  2009cited by this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *

  2008cited by this paper
• Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis

  2007cited by this paper
• EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria

  2006cited by this paper
• Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial.

  2006cited by this paper
• Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria

  2006cited by this paper
• Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double‐blind, placebo‐controlled study

  2006cited by this paper
• Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.

  2006cited by this paper
• Desloratadine therapy for symptoms associated with perennial allergic rhinitis.

  2006cited by this paper
• EAACI/GA2LEN/EDF guideline: management of urticaria

  2006cited by this paper
• Allergic Rhinitis

  2005cited by this paper
• Inhibition of cold urticaria by desloratadine

  2004cited by this paper
• Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.

  2003cited by this paper
• The role of histamine in allergic disease: re‐appraisal of its inflammatory potential

  2002cited by this paper
• Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.

  2002cited by this paper
• 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]

  2002cited by this paper
• Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis

  2001cited by this paper
• Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study.

  2001cited by this paper
• Desloratadine: A new, nonsedating, oral antihistamine.

  2001cited by this paper
• The pharmacologic profile of desloratadine: a review

  2001cited by this paper
• Desloratadine activity in concurrent seasonal allergic rhinitis and asthma

  2001cited by this paper
• Once‐daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled study

  2001cited by this paper
• Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis

  2001cited by this paper
• Preclinical Pharmacology of Desloratadine, a Selective and Nonsedating Histamine H1 Receptor Antagonist2nd Communication: Lack of central nervous system and cardiovascular effects

  2000cited by this paper
• Preclinical Pharmacology of Desloratadine, a Selective and Nonsedating Histamine H1 Receptor Antagonist

  2000cited by this paper
• Pros and cons of the use of antihistamines in managing allergic rhinitis.

  1999cited by this paper
• Acute urticaria: clinical aspects and therapeutic responsiveness.

  1996cited by this paper
• Comparative safety of H1 antihistamines.

  1991cited by this paper
• The role of antihistamines in the treatment of chronic urticaria.

  1990cited by this paper
• In vivo studies of mediator release in cold urticaria and cholinergic urticaria.

  1975cited by this paper

• No citing papers are available for this paper.